API
< Back to situations

[ORGANIZATION]

Roche

Featured in 88 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [US] [CH]

Novartis remibrutinib clinical development

3 clusters · 12 sources · last updated

Latest: Novartis projects $4 billion in peak sales for MS drug remibrutinib

Novartis is advancing the clinical application of remibrutinib, an oral Bruton tyrosine kinase (BTK) inhibitor, across different medical indications. In October 2026, the US Food and Drug Administration (FDA) approved r

[ACTIVE] [POLITICS] [VE] [MX] [CO]

Venezuela electricity rationing and infrastructure crisis

24 clusters · 83 sources · last updated

Latest: Power outages reported in Mérida, Venezuela and Mexico

Public utility and infrastructure services in Venezuela continue to face severe operational challenges, primarily driven by a deteriorating electrical grid and widespread energy rationing. While the capital region experi

[ACTIVE] [HEALTH] [AR] [DO] [ES]

Expansion of cancer awareness and prevention initiatives

5 clusters · 114 sources · last updated

Latest: Breast cancer awareness initiatives launched across Latin America

Health and cancer awareness initiatives continue to expand across Latin America and Spain, with a heightened focus on breast cancer during ‘Pink October’. In Argentina, community-based support and prevention efforts have

[ACTIVE] [BUSINESS] [DE] [BR] [CH]

SAP product strategy and financial growth

5 clusters · 23 sources · last updated

Latest: SAP reports strong cloud and AI adoption in Latin America

SAP is undergoing a strategic shift focused on artificial intelligence and cloud expansion. The German-speaking SAP User Group (DSAG) has advocated for clearer AI governance guidelines and greater flexibility in operatin

[ACTIVE] [BUSINESS] [CH]

Swiss stock market performance

2 clusters · 9 sources · last updated

Latest: Swiss stock market reaches new all-time high

The Swiss stock market has experienced recent volatility and slight declines. On October 26, the Swiss Leader Index (SLI) opened lower by 0.067 percent to 2,335.43 points, though it maintained a year-to-date increase of

[ACTIVE] [HEALTH] [AR] [BH] [CL]

Global Breast Cancer Awareness and Prevention Efforts

8 clusters · 422 sources · last updated

Latest: Pink October campaign faces criticism over overdiagnosis and pinkwashing

Regional health authorities across South America, Southeast Asia, and Europe continue to implement medical expansions and disease prevention measures. In Venezuela, efforts focus on medical infrastructure improvements an

[ACTIVE] [HEALTH] [US] [DE] [JP]

Lifestyle, prevention, and diagnostic research in dementia

31 clusters · 101 sources · last updated

Latest: Research identifies modifiable risk factors for dementia prevention

Research continues to link lifestyle habits with reduced risks of cardiovascular disease, obesity, and cognitive decline. Studies from King’s College London indicate that dietary modifications—such as increasing fruit an

[ACTIVE] [HEALTH] [US]

Radical Numerics AI-designed phage therapy progress

2 clusters · 9 sources · last updated

Latest: Radical Numerics uses AI to design virus for human clinical trial

The US-based startup Radical Numerics has reported the administration of an AI-designed bacteriophage cocktail to a human patient suffering from a multi-drug resistant bacterial infection. The treatment, utilizing the co

[ACTIVE] [BUSINESS] [CH] [DE]

Roche investment suspension in Germany

2 clusters · 26 sources · last updated

Latest: Roche suspends new investments in Germany

Swiss pharmaceutical company Roche has announced a temporary suspension of all future investment decisions in Germany. The company cited a significant loss of confidence in the German government’s healthcare policies as

[ACTIVE] [HEALTH] [US]

FDA approval of bepirovirsen for hepatitis B

2 clusters · 4 sources · last updated

Latest: FDA approves bepirovirsen for functional hepatitis B cure

The U.S. Food and Drug Administration (FDA) has approved Hibsago (bepirovirsen), an injection developed by GSK, for treating chronic hepatitis B virus (HBV) infection in certain adults without cirrhosis. As the first ant

[ACTIVE] [HEALTH] [BR] [PY] [FR]

Brazil ANVISA expands product safety enforcement

43 clusters · 290 sources · last updated

Latest: Anvisa bans Accu-Chek Active glucose test strips on Amazon

Since May 2026, Brazil’s National Health Surveillance Agency (ANVISA) has intensified enforcement of sanitary rules for pharmaceuticals, cosmetics, and consumer goods. Early actions included suspending batches of statins

[ACTIVE] [HEALTH] [US] [DE] [GB]

Global Alzheimer's prevalence and diagnostic advancements

15 clusters · 57 sources · last updated

Latest: Researchers advance neurodegenerative disease diagnostics and theories

Medical experts continue to highlight the rising prevalence of Alzheimer’s disease as global life expectancy increases. Projections suggest the number of people living with dementia could rise from 57 million in 2021 to

[QUIET] [HEALTH] [ES]

ESMO 2026 oncology clinical data presentations

2 clusters · 4 sources · last updated

Latest: Biotech companies present new ADC clinical data at ESMO 2026

During the 2026 European Society for Medical Oncology (ESMO) Annual Meeting, several biotechnology and pharmaceutical companies presented new clinical trial data regarding cancer treatments. Roche and Genentech reported

[QUIET] [HEALTH] [US]

FDA approval of GSK Hibsago for hepatitis B

2 clusters · 18 sources · last updated

Latest: FDA approves GSK drug Hibsago for chronic hepatitis B

The U.S. Food and Drug Administration (FDA) has approved Hibsago (bepirovirsen), an injectable antisense oligonucleotide developed by GSK, for treating chronic hepatitis B in certain adults. This represents the first FDA

[QUIET] [HEALTH] [EU] [IT]

EMA CHMP and EU Commission medicinal product approvals

3 clusters · 24 sources · last updated

Latest: European Commission approves Ocrevus for pediatric multiple sclerosis

In September 2026, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended the approval of 12 new medicines and therapeutic extensions for 11 existing ones. Among the

[QUIET] [TECHNOLOGY] [US] [IT] [AU]

AI healthcare integration expands amid privacy and cost

24 clusters · 107 sources · last updated

Latest: US healthcare groups urge FDA to hold AI developers accountable

Since the July 2026 summit, AI deployment in healthcare has accelerated toward a collaborative model, though integration is increasingly complicated by privacy, economic, and safety tensions. Clinicians are adopting too

[QUIET] [BUSINESS] [CH] [DE] [US]

Swiss pharmaceutical industry trends and growth

2 clusters · 16 sources · last updated

Latest: Roche CEO warns Europe is losing its competitive edge

The Swiss pharmaceutical sector is seeing a significant shift toward outsourcing development and manufacturing to specialized Contract Development and Manufacturing Organizations (CDMOs). Analysts indicate that the share

[QUIET] [BUSINESS] [CH] [CN] [US]

Swiss watch and gold export trends

2 clusters · 11 sources · last updated

Latest: Swiss exports see growth in watch and gold sectors

In September 2026, the Swiss watch industry reported an 11.7 percent increase in exports, totaling 2.23 billion francs. This growth follows three consecutive months of expansion, bringing the total for the first nine mon

[QUIET] [BUSINESS] [CH] [CN] [US]

Roche pharmaceutical licensing expansions

2 clusters · 6 sources · last updated

Latest: Roche and Hansoh Pharma sign second ADC licensing deal

Roche has entered into several high-value licensing agreements to expand its pharmaceutical pipeline across multiple therapeutic areas. In mid-October 2026, the company secured global rights to Alector’s preclinical Par

[QUIET] [BUSINESS] [ES] [US]

Thyroid eye disease drug funding dispute in Spain

2 clusters · 7 sources · last updated

Latest: Roche receives FDA approval for Enspryng to treat thyroid eye disease

In Spain, the Spanish Association of Patients with Thyroid Eye Disease (EOT España) is demanding that the Ministry of Health and autonomous communities rectify a decision to deny funding for teprotumumab. The association

[QUIET] [HEALTH] [CR] [CO] [DO]

Latin American healthcare economic investment advocacy

2 clusters · 6 sources · last updated

Latest: Latin America urged to treat healthcare as strategic economic investment

Experts and health officials are advocating for a regional shift in Latin America, urging policymakers to view healthcare as a strategic economic investment rather than a public expense. Initial reports highlight the po

[QUIET] [BUSINESS] [AR] [BR] [EU]

Mercosur-EU trade agreements with EU and EFTA

12 clusters · 64 sources · last updated

Latest: Brazil exports to EU rise 30% under Mercosur agreement

Following the provisional implementation of the Mercosur–EU agreement on May 1, 2026, trade dynamics have shifted significantly. In Argentina, exports to the EU rose by 19% during the first seven months of 2026, totaling

[QUIET] [BUSINESS] [CH] [JP] [US]

Roche Holding AG analyst rating updates

2 clusters · 3 sources · last updated

Latest: Japanese companies see stock price target increases

Financial analysts have updated their forecasts and ratings for Roche Holding AG. While Erste Group Bank lowered its FY2026 earnings per share estimate for the company to $3.05 from a previous $3.14, the consensus estima

[QUIET] [HEALTH] [BR]

Brazil updates blood donation rules and improves logistics

6 clusters · 82 sources · last updated

Latest: Brazil updates blood donation rules and expands infrastructure

Brazil continues to modernize its hemotherapy sector through updated regulatory frameworks and infrastructure investments. Following new Ministry of Health guidelines, donation eligibility has been expanded to include re

[QUIET] [HEALTH] [US] [AU] [GB]

Advancements in Alzheimer's detection, AI, and drug access

18 clusters · 83 sources · last updated

Latest: Dementia diagnosis and new drugs improve patient outlook

Research into Alzheimer's biomarkers continues to evolve, with recent findings refining the utility of blood-based testing. While plasma p-tau217 remains a key indicator, studies suggest its predictive power in symptom-f

[QUIET] [HEALTH] [US] [CH] [DK]

Clinical developments in obesity and diabetes medications

2 clusters · 12 sources · last updated

Latest: Zealand Pharma reports positive Phase 2 results for obesity drug petrelintide

Pharmaceutical developments regarding experimental treatments for obesity and type 2 diabetes have shown positive results in Phase II clinical trials. In late September 2026, Roche and Genentech reported successful Phas

[QUIET] [HEALTH] [IT] [US]

Pancreatic cancer treatment and care advancements

2 clusters · 10 sources · last updated

Latest: Pancreatic cancer research and care models see new developments

Developments in pancreatic cancer treatment are focusing on both clinical immunotherapy breakthroughs and improved healthcare delivery models. Clinical research has highlighted the potential of cancer vaccines to train

[QUIET] [HEALTH] [BR] [CN] [ID]

Global generic production of baloxavir marboxil

2 clusters · 5 sources · last updated

Latest: Fidson Healthcare to manufacture generic Roche influenza drug

A voluntary licensing agreement between Roche and the Medicines Patent Pool (MPP) is facilitating the production of generic versions of the antiviral influenza treatment, baloxavir marboxil. This initiative aims to suppl

[QUIET] [HEALTH] [CI] [BF] [GA]

Cancer awareness and screening in West and Central Africa

2 clusters · 14 sources · last updated

Latest: West Africa intensifies cancer screening and diagnostic efforts

Health organizations and authorities in West and Central African nations have initiated various campaigns to improve cancer awareness, screening, and diagnostic capabilities. In September, Côte d’Ivoire and Gabon launch

[QUIET] [BUSINESS] [CH] [US] [CN]

Pharmaceutical industry drug discovery partnerships

2 clusters · 6 sources · last updated

Latest: Novartis and Sanofi lead major pharmaceutical licensing and alliance expansions

Major pharmaceutical companies are entering large-scale partnerships to advance drug discovery and development through specialized technologies. In late September 2026, Boehringer Ingelheim expanded its collaboration wi

Also covered in